P3.13-22 Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients with EGFR Mutant Non-Small Cell Lung Cancer.
2018 ◽
Vol 13
(10)
◽
pp. S984
H. Tanaka
◽
K. Taima
◽
M. Itoga
◽
Y. Ishioka
◽
K. Baba
◽
...
Martina Lorenzi
◽
Alessandra Ferro
◽
Fabiana Cecere
◽
Daniela Scattolin
◽
Alessandro Del Conte
◽
...
Hisashi Tanaka
◽
Kageaki Taima
◽
Masamichi Itoga
◽
Yoshiko Ishioka
◽
Keisuke Baba
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S848
C.K. Liam
◽
C. Chai
◽
G. Ho
◽
A. Alip
◽
M.I.A. Wahid
◽
...
2019 ◽
Vol 30
◽
pp. ix163
S.H. Yoon
◽
Y.S. Kim
◽
J.H. Chung
◽
H.Y. Seol
◽
M.H. Kim
2021 ◽
Vol 16
(4)
◽
pp. S779
M. Lorenzi
◽
A. Dal Maso
◽
A. Ferro
◽
V. Polo
◽
D. Scattolin
◽
...
2018 ◽
Vol 13
(10)
◽
pp. S998-S999
◽
C. Liam
◽
G. Ho
◽
C. Chai
◽
A. Bt Alip
◽
Y. Pang
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21173-e21173
Hisashi Tanaka
◽
Kageaki Taima
◽
Masamichi Itoga
◽
Yoshiko Ishioka
◽
Keisuke Baba
◽
...
Y. Belaroussi
◽
S. Cousin
◽
M. Carton
◽
M. Lebitasy
◽
L. Laborde
◽
...
2021 ◽
Vol 10
(9)
◽
pp. 3782-3792
Xin Yu
◽
Jiaqi Li
◽
Lingyun Ye
◽
Jing Zhao
◽
Mengqing Xie
◽
...
2021 ◽
Vol 16
(10)
◽
pp. S1113
J. Nieva
◽
A. Taylor
◽
L. Servidio
◽
P. Sun
◽
P. Okhuoya
◽
...